Buscar
Mostrando ítems 41-50 de 167
Conjugate vaccines and pneumococcal disease in Ecuador [Las vacunas conjugadas y la enfermedad neumocócica en Ecuador]
(EDICIONES DOYMA S.L., 2014-01-01)
Introduction: Streptococcus pneumoniae is responsible for invasive and noninvasive infections in children under 5 and adults over 65 years, the pathologies associated with this pathogen are pneumonia, ear infections, ...
Key features of invasive pneumococcal isolates recovered in Lima, Peru determined through whole genome sequencing
(Elsevier, 2017)
Before PCV7 introduction, invasive pneumococcal disease (IPD) was responsible for approximately 12,000-18,000 deaths annually among children <5years in Latin America. In Peru, PCV7 was introduced in 2009. We used whole ...
Cost effectiveness of heptavalent pneumococcal conjugate vaccine in populations of high risk in Colombia.
(2011-11-11)
Objective: To estimate the economic impact of the introduction of heptavalent pneumococcal conjugate vaccine (PCV-
7) in high risk populations of Colombia.
Methods: A full economic evaluation was done regarding potential ...
Transmission of Streptococcus pneumoniae in an urban slum community
(2008)
Background: Inhabitants of slum settlements represent a significant proportion of
the population at risk for pneumococcal disease in developing countries. Methods: We conducted a household survey of pneumococcal carriage ...
Análisis económico de las vacunas 10-valente y 13-valente contra neumococo: revisión sistemática
(Universidad del RosarioFacultad de medicina, 2014)
Introduction: An easy and effective method for control and prevention of multiple infectious diseases has been massive vaccination. Lately, two new conjugate vaccines against pneumococcus appeared at high prices, and ...
Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia
(Taylor & Francis Group, LLCHuman Vaccines and Immunotherapeutics, 2020)